Accessibility Menu
GoodRx logo

GoodRx

(NASDAQ) GDRX

Current Price$2.83
Market Cap$911.04M
Since IPO (2020)-94%
5 Year-93%
1 Year-43%
1 Month-2%

GoodRx Financials at a Glance

Market Cap

$911.04M

Revenue (TTM)

$787.89M

Net Income (TTM)

$20.56M

EPS (TTM)

$0.06

P/E Ratio

45.98

Dividend

$0.00

Beta (Volatility)

1.75 (High)

Price

$2.83

Volume

1,075,241.156

Open

$2.67

Previous Close

$2.80

Daily Range

$2.64 - $2.83

52-Week Range

$1.77 - $5.81

Estimated Earnings Date

Aug 5, 2026

GDRX: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GoodRx

Industry

Health Care Technology

Employees

697

CEO

Wendy Barnes, MBA

Headquarters

Santa Monica, CA 90404, US

GDRX Financials

Key Financial Metrics (TTM)

Gross Margin

86.56%

Operating Margin

10.73%

Net Income Margin

2.61%

Return on Equity

3.31%

Return on Capital

7.55%

Return on Assets

1.02%

Earnings Yield

2.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$911.04M

Shares Outstanding

338.68M

Volume

1.08M

Avg. Volume

1.53M

Financials (TTM)

Gross Profit

$681.98M

Operating Income

$84.56M

EBITDA

$173.34M

Operating Cash Flow

$170.33M

Capital Expenditure

-$53.28M

Free Cash Flow

$117.05M

Cash & ST Invst.

$235.71M

Total Debt

$541.35M

GoodRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$194.01M

-4.4%

Gross Profit

$152.06M

-19.8%

Gross Margin

78.38%

N/A

Market Cap

$911.04M

N/A

Market Cap/Employee

$1.23M

N/A

Employees

738

N/A

Net Income

$1.17M

-89.4%

EBITDA

$37.20M

-22.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$235.71M

-21.7%

Total Debt

$541.35M

+0.0%

Accounts Receivable

$244.62M

+42.2%

Inventory

$0.00

N/A

Long Term Debt

$531.38M

+0.1%

Short Term Debt

$9.98M

-5.5%

Return on Assets

1.02%

N/A

Return on Invested Capital

7.28%

N/A

Free Cash Flow

$10.70M

+185.9%

Operating Cash Flow

$11.84M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMPHAmphastar Pharmaceuticals, Inc.
$21.78+3.52%
HSTMHealthStream, Inc.
$26.73+4.01%
COLLCollegium Pharmaceutical, Inc.
$36.59+5.02%
IRMDIRadimed Corporation
$93.96+0.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%
SOFISoFi Technologies
$17.88+0.03%

Questions About GDRX

What is the current price of GoodRx?

GoodRx is trading at $2.80 per share.

What is the 52-week range for GoodRx?

Over the past 52 weeks, GoodRx has traded between $1.77 and $5.81.

How much debt does GoodRx have?

As of the most recent reporting period, GoodRx reported total debt of $541.35M.

How much cash does GoodRx have on hand?

GoodRx reported $235.71M in cash and cash equivalents in its most recent financial results.

What is GoodRx’s dividend yield?

GoodRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.